Twist Bioscience to Present at Upcoming Investor Conferences
February 28 2023 - 8:00AM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA using its silicon platform, today announced that Emily M.
Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim
Thorburn, CFO of Twist Bioscience, will present at the following
upcoming investor conferences:
- Cowen 43rd Annual Healthcare Conference in Boston, MA;
- Fireside chat on Tuesday, March 7 at 1:30 p.m. Eastern
Time.
- SynBio & AI Driven Drug Discovery Panel: Monday, March 6 at
4:40 p.m. Eastern Time.
- Synthetic Biology Enabling Tools Panel: Tuesday, March 7 at
4:40 p.m. Eastern Time.
- Barclays Global Healthcare Conference on Tuesday, March 14 in
Miami, FL; fireside chat at 2:05 p.m. Eastern Time.
The Cowen fireside chat and panels and Barclays fireside chat
will be webcast live and can be accessed by visiting the “Investor
Calendar” page of the investor relations section of the company's
website here. A replay of the fireside chats will be
archived for a period of 30 days following the conclusion of the
live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook |
LinkedIn | YouTube
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230227005204/en/
For Twist Bioscience Angela Bitting SVP, Corporate
Affairs 925- 202-6211 media@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jul 2023 to Jul 2024